nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—TLR4—periodontitis	0.866	1	CbGaD
Naloxone—ESR1—periosteum—periodontitis	0.00319	0.224	CbGeAlD
Naloxone—CREB1—mouth—periodontitis	0.00231	0.162	CbGeAlD
Naloxone—CREB1—neck—periodontitis	0.00197	0.138	CbGeAlD
Naloxone—CREB1—trigeminal ganglion—periodontitis	0.0017	0.119	CbGeAlD
Naloxone—CREB1—connective tissue—periodontitis	0.00141	0.0991	CbGeAlD
Naloxone—CREB1—epithelium—periodontitis	0.00134	0.0941	CbGeAlD
Naloxone—ESR1—neck—periodontitis	0.000776	0.0544	CbGeAlD
Naloxone—ESR1—connective tissue—periodontitis	0.000556	0.039	CbGeAlD
Naloxone—ESR1—epithelium—periodontitis	0.000528	0.037	CbGeAlD
Naloxone—ABCB1—trigeminal ganglion—periodontitis	0.000265	0.0186	CbGeAlD
Naloxone—ABCB1—epithelium—periodontitis	0.000209	0.0146	CbGeAlD
Naloxone—TLR4—Immune System—FGF2—periodontitis	6.19e-05	0.000519	CbGpPWpGaD
Naloxone—CREB1—Adipogenesis—IL6—periodontitis	6.01e-05	0.000503	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—CXCR2—periodontitis	5.97e-05	0.0005	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—PTGS2—periodontitis	5.96e-05	0.000499	CbGpPWpGaD
Naloxone—OPRM1—TCR Signaling Pathway—IL6—periodontitis	5.95e-05	0.000499	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—IFNG—periodontitis	5.93e-05	0.000497	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	5.89e-05	0.000493	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	5.88e-05	0.000493	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	5.86e-05	0.000491	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	5.85e-05	0.00049	CbGpPWpGaD
Naloxone—OPRM1—Peptide ligand-binding receptors—CXCL8—periodontitis	5.83e-05	0.000489	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—CCR2—periodontitis	5.83e-05	0.000489	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—PPARA—periodontitis	5.83e-05	0.000488	CbGpPWpGaD
Naloxone—TLR4—Immune System—IFNG—periodontitis	5.82e-05	0.000488	CbGpPWpGaD
Naloxone—OPRK1—G alpha (i) signalling events—CXCL8—periodontitis	5.82e-05	0.000488	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—ADRB1—periodontitis	5.8e-05	0.000486	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—AGER—periodontitis	5.72e-05	0.00048	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	5.7e-05	0.000478	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—VIP—periodontitis	5.66e-05	0.000474	CbGpPWpGaD
Naloxone—CREB1—Toll-Like Receptors Cascades—IL6—periodontitis	5.63e-05	0.000472	CbGpPWpGaD
Naloxone—CREB1—Signaling by SCF-KIT—IL6—periodontitis	5.63e-05	0.000472	CbGpPWpGaD
Naloxone—CREB1—Immune System—FCGR2A—periodontitis	5.6e-05	0.000469	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—CXCR2—periodontitis	5.55e-05	0.000466	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—IL1B—periodontitis	5.54e-05	0.000465	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—CXCL8—periodontitis	5.52e-05	0.000463	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CXCL3—periodontitis	5.47e-05	0.000459	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	5.47e-05	0.000458	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling of activated FGFR—IL6—periodontitis	5.38e-05	0.000451	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—CCR2—periodontitis	5.31e-05	0.000445	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	5.31e-05	0.000445	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—MET—periodontitis	5.3e-05	0.000444	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB4—IL6—periodontitis	5.3e-05	0.000444	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—IL1B—periodontitis	5.29e-05	0.000444	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—CCR2—periodontitis	5.29e-05	0.000444	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—ADRB1—periodontitis	5.29e-05	0.000443	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	5.28e-05	0.000442	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—ADRB1—periodontitis	5.27e-05	0.000442	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—IL6—periodontitis	5.22e-05	0.000438	CbGpPWpGaD
Naloxone—CREB1—Myometrial Relaxation and Contraction Pathways—IL6—periodontitis	5.22e-05	0.000437	CbGpPWpGaD
Naloxone—TLR4—Immune System—IL1B—periodontitis	5.19e-05	0.000435	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—IL6—periodontitis	5.19e-05	0.000435	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—CCR2—periodontitis	5.11e-05	0.000428	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—ADRB1—periodontitis	5.09e-05	0.000426	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—CCL2—periodontitis	5.08e-05	0.000426	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—TNF—periodontitis	5.06e-05	0.000424	CbGpPWpGaD
Naloxone—CREB1—Downstream signal transduction—IL6—periodontitis	5.06e-05	0.000424	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—CXCR2—periodontitis	5.04e-05	0.000423	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR—IL6—periodontitis	5.04e-05	0.000422	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—IL6—periodontitis	5.02e-05	0.000421	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB2—IL6—periodontitis	5.01e-05	0.00042	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CRP—periodontitis	4.99e-05	0.000418	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—IL6—periodontitis	4.99e-05	0.000418	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	4.95e-05	0.000415	CbGpPWpGaD
Naloxone—OPRM1—G alpha (i) signalling events—CXCL8—periodontitis	4.92e-05	0.000412	CbGpPWpGaD
Naloxone—CREB1—Immune System—CCR2—periodontitis	4.85e-05	0.000407	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL1RN—periodontitis	4.83e-05	0.000405	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—VDR—periodontitis	4.81e-05	0.000403	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—TLR4—periodontitis	4.78e-05	0.000401	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ACP5—periodontitis	4.71e-05	0.000395	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—IL6—periodontitis	4.69e-05	0.000393	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—IL6—periodontitis	4.69e-05	0.000393	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—IL6—periodontitis	4.69e-05	0.000393	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—MMP9—periodontitis	4.66e-05	0.00039	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—IL6—periodontitis	4.65e-05	0.00039	CbGpPWpGaD
Naloxone—ALB—Platelet degranulation—TGFB1—periodontitis	4.65e-05	0.00039	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—CCR2—periodontitis	4.64e-05	0.000389	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	4.63e-05	0.000388	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CXCL3—periodontitis	4.62e-05	0.000388	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—ADRB1—periodontitis	4.62e-05	0.000387	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—IL6—periodontitis	4.61e-05	0.000386	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—IL6—periodontitis	4.59e-05	0.000385	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—VIP—periodontitis	4.52e-05	0.000379	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—VIP—periodontitis	4.51e-05	0.000378	CbGpPWpGaD
Naloxone—CREB1—Immune System—TLR2—periodontitis	4.51e-05	0.000378	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—CCL2—periodontitis	4.46e-05	0.000374	CbGpPWpGaD
Naloxone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—periodontitis	4.43e-05	0.000371	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—MMP2—periodontitis	4.42e-05	0.000371	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—CCR2—periodontitis	4.32e-05	0.000362	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—ADRB1—periodontitis	4.3e-05	0.00036	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD79A—periodontitis	4.24e-05	0.000355	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—IL6—periodontitis	4.24e-05	0.000355	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	4.21e-05	0.000353	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—FGF2—periodontitis	4.2e-05	0.000352	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—IL6—periodontitis	4.16e-05	0.000348	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—TGFB1—periodontitis	4.11e-05	0.000345	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CXCL3—periodontitis	4.1e-05	0.000344	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—IL6—periodontitis	4.09e-05	0.000342	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD14—periodontitis	4.07e-05	0.000341	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—PPARA—periodontitis	4.05e-05	0.00034	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—GGT1—periodontitis	4.04e-05	0.000339	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CXCR2—periodontitis	4.03e-05	0.000338	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—MMP3—periodontitis	4.02e-05	0.000337	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—TNF—periodontitis	4.02e-05	0.000337	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CXCR2—periodontitis	4.02e-05	0.000337	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—CXCL8—periodontitis	4.02e-05	0.000337	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	4.02e-05	0.000337	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—MMP3—periodontitis	4.01e-05	0.000336	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—PPARA—periodontitis	4.01e-05	0.000336	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—VIP—periodontitis	3.96e-05	0.000332	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—SLC52A3—periodontitis	3.93e-05	0.000329	CbGpPWpGaD
Naloxone—CREB1—Immune System—VCAM1—periodontitis	3.92e-05	0.000329	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—CCR2—periodontitis	3.92e-05	0.000329	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	3.91e-05	0.000328	CbGpPWpGaD
Naloxone—ALB—Metabolism—SLC52A3—periodontitis	3.91e-05	0.000327	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—ADRB1—periodontitis	3.9e-05	0.000327	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—TNF—periodontitis	3.84e-05	0.000322	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	3.84e-05	0.000322	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—CCL2—periodontitis	3.77e-05	0.000316	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—FGF2—periodontitis	3.71e-05	0.000311	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	3.58e-05	0.0003	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TIMP1—periodontitis	3.57e-05	0.000299	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—FGF2—periodontitis	3.56e-05	0.000299	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CXCR2—periodontitis	3.53e-05	0.000295	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—CXCL8—periodontitis	3.52e-05	0.000295	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—MMP3—periodontitis	3.52e-05	0.000295	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL1A—periodontitis	3.48e-05	0.000291	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—IL6—periodontitis	3.47e-05	0.000291	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL18—periodontitis	3.47e-05	0.000291	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—SLC52A3—periodontitis	3.42e-05	0.000287	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—VIP—periodontitis	3.34e-05	0.00028	CbGpPWpGaD
Naloxone—CREB1—Immune System—AGER—periodontitis	3.33e-05	0.000279	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—MMP9—periodontitis	3.32e-05	0.000279	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—IL6—periodontitis	3.25e-05	0.000272	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—IL6—periodontitis	3.2e-05	0.000268	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CCR2—periodontitis	3.14e-05	0.000263	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CCR2—periodontitis	3.13e-05	0.000262	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—ADRB1—periodontitis	3.12e-05	0.000262	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	3.11e-05	0.000261	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—ADRB1—periodontitis	3.11e-05	0.000261	CbGpPWpGaD
Naloxone—TLR4—Immune System—IL6—periodontitis	3.04e-05	0.000255	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CXCR2—periodontitis	2.98e-05	0.00025	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—CXCL8—periodontitis	2.98e-05	0.00025	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—MMP3—periodontitis	2.97e-05	0.000249	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—VIP—periodontitis	2.96e-05	0.000248	CbGpPWpGaD
Naloxone—CREB1—Immune System—CRP—periodontitis	2.91e-05	0.000244	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—IL6—periodontitis	2.89e-05	0.000242	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—periodontitis	2.89e-05	0.000242	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—GGT1—periodontitis	2.88e-05	0.000241	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	2.81e-05	0.000235	CbGpPWpGaD
Naloxone—CREB1—Immune System—TLR4—periodontitis	2.79e-05	0.000234	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CCR2—periodontitis	2.74e-05	0.00023	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—TGFB1—periodontitis	2.74e-05	0.00023	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	2.74e-05	0.00023	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—ADRB1—periodontitis	2.73e-05	0.000229	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CXCR2—periodontitis	2.64e-05	0.000221	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GGT1—periodontitis	2.62e-05	0.00022	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—CCL2—periodontitis	2.62e-05	0.000219	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—CCL2—periodontitis	2.61e-05	0.000219	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—TNF—periodontitis	2.56e-05	0.000214	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NTRK1—periodontitis	2.56e-05	0.000214	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NTRK1—periodontitis	2.55e-05	0.000214	CbGpPWpGaD
Naloxone—CREB1—Disease—NOS2—periodontitis	2.45e-05	0.000205	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MMP3—periodontitis	2.38e-05	0.000199	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MMP3—periodontitis	2.37e-05	0.000199	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CCR2—periodontitis	2.32e-05	0.000194	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ACP5—periodontitis	2.32e-05	0.000194	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—VDR—periodontitis	2.31e-05	0.000194	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—ADRB1—periodontitis	2.31e-05	0.000193	CbGpPWpGaD
Naloxone—ALB—Metabolism—ACP5—periodontitis	2.3e-05	0.000193	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—CCL2—periodontitis	2.29e-05	0.000192	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—CXCL8—periodontitis	2.27e-05	0.00019	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NTRK1—periodontitis	2.23e-05	0.000187	CbGpPWpGaD
Naloxone—ALB—Hemostasis—MMP1—periodontitis	2.22e-05	0.000186	CbGpPWpGaD
Naloxone—CREB1—Immune System—FGF2—periodontitis	2.16e-05	0.000181	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—SLC52A3—periodontitis	2.11e-05	0.000177	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MMP3—periodontitis	2.08e-05	0.000174	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—periodontitis	2.07e-05	0.000173	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—CXCL8—periodontitis	2.07e-05	0.000173	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—IL6—periodontitis	2.06e-05	0.000173	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—CXCL8—periodontitis	2.06e-05	0.000173	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—TGFB1—periodontitis	2.06e-05	0.000173	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PPARA—periodontitis	2.06e-05	0.000173	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CCR2—periodontitis	2.05e-05	0.000172	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—ADRB1—periodontitis	2.05e-05	0.000171	CbGpPWpGaD
Naloxone—CREB1—Immune System—IFNG—periodontitis	2.03e-05	0.00017	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	2.03e-05	0.00017	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ACP5—periodontitis	2.02e-05	0.000169	CbGpPWpGaD
Naloxone—ALB—Hemostasis—NOS2—periodontitis	2e-05	0.000168	CbGpPWpGaD
Naloxone—CREB1—Disease—FGF2—periodontitis	1.99e-05	0.000167	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—CXCL8—periodontitis	1.99e-05	0.000167	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—PPARA—periodontitis	1.96e-05	0.000164	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—PPARA—periodontitis	1.95e-05	0.000164	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—CCL2—periodontitis	1.93e-05	0.000162	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	1.9e-05	0.000159	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NTRK1—periodontitis	1.89e-05	0.000158	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PPARA—periodontitis	1.88e-05	0.000157	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—IL6—periodontitis	1.82e-05	0.000153	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL1B—periodontitis	1.81e-05	0.000152	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—CXCL8—periodontitis	1.81e-05	0.000152	CbGpPWpGaD
Naloxone—CREB1—Disease—PTGS2—periodontitis	1.8e-05	0.000151	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MMP3—periodontitis	1.76e-05	0.000147	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—PPARA—periodontitis	1.71e-05	0.000144	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—CXCL8—periodontitis	1.68e-05	0.000141	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NTRK1—periodontitis	1.67e-05	0.00014	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MMP3—periodontitis	1.56e-05	0.000131	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CCL2—periodontitis	1.55e-05	0.00013	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CCL2—periodontitis	1.54e-05	0.000129	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—CXCL8—periodontitis	1.53e-05	0.000128	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FGF2—periodontitis	1.4e-05	0.000117	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FGF2—periodontitis	1.39e-05	0.000117	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CCL2—periodontitis	1.35e-05	0.000113	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	1.35e-05	0.000113	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	1.34e-05	0.000112	CbGpPWpGaD
Naloxone—CREB1—Disease—TGFB1—periodontitis	1.3e-05	0.000109	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GGT1—periodontitis	1.29e-05	0.000108	CbGpPWpGaD
Naloxone—ALB—Metabolism—GGT1—periodontitis	1.28e-05	0.000107	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ACP5—periodontitis	1.24e-05	0.000104	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CXCL8—periodontitis	1.22e-05	0.000102	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FGF2—periodontitis	1.22e-05	0.000102	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PTGS2—periodontitis	1.22e-05	0.000102	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CXCL8—periodontitis	1.22e-05	0.000102	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—IL6—periodontitis	1.16e-05	9.74e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—IL6—periodontitis	1.16e-05	9.71e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CCL2—periodontitis	1.14e-05	9.57e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GGT1—periodontitis	1.12e-05	9.41e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MMP9—periodontitis	1.11e-05	9.26e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MMP9—periodontitis	1.1e-05	9.23e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CXCL8—periodontitis	1.07e-05	8.95e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TGFB1—periodontitis	1.06e-05	8.91e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL6—periodontitis	1.06e-05	8.9e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FGF2—periodontitis	1.03e-05	8.65e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—IL6—periodontitis	1.02e-05	8.51e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CCL2—periodontitis	1.01e-05	8.49e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—IL6—periodontitis	9.8e-06	8.22e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MMP9—periodontitis	9.66e-06	8.1e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PPARA—periodontitis	9.22e-06	7.73e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PPARA—periodontitis	9.17e-06	7.68e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FGF2—periodontitis	9.15e-06	7.67e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TGFB1—periodontitis	9.11e-06	7.64e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TGFB1—periodontitis	9.08e-06	7.61e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CXCL8—periodontitis	9.03e-06	7.57e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—IL6—periodontitis	8.58e-06	7.19e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MMP9—periodontitis	8.16e-06	6.84e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PPARA—periodontitis	8.03e-06	6.73e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CXCL8—periodontitis	8e-06	6.71e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TGFB1—periodontitis	7.96e-06	6.67e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MMP9—periodontitis	7.24e-06	6.07e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GGT1—periodontitis	6.91e-06	5.79e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IL6—periodontitis	6.86e-06	5.75e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IL6—periodontitis	6.84e-06	5.74e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TGFB1—periodontitis	6.73e-06	5.64e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IL6—periodontitis	6e-06	5.03e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PTGS2—periodontitis	5.99e-06	5.02e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TGFB1—periodontitis	5.97e-06	5e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PTGS2—periodontitis	5.96e-06	5e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PTGS2—periodontitis	5.22e-06	4.38e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IL6—periodontitis	5.07e-06	4.25e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PPARA—periodontitis	4.95e-06	4.15e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL6—periodontitis	4.5e-06	3.77e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PTGS2—periodontitis	3.22e-06	2.7e-05	CbGpPWpGaD
